Search Results - Ekyalongo, Roudy Chiminch

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Revisiting the IGF-1R as a breast cancer target

    Revisiting the IGF-1R as a breast cancer target by Ekyalongo, Roudy Chiminch, Yee, Douglas

    Published in NPJ precision oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line

    Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line by FUNAKOSHI, Yohei, MUKOHARA, Toru, MINAMI, Hironobu, TOMIOKA, Hideo, ROUDY CHIMINCH EKYALONGO, KATAOKA, Yu, INUI, Yumiko, KAWAMORI, Yuriko, TOYODA, Masanori, KIYOTA, Naomi, FUJIWARA, Yutaka

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    TYRO3 as a potential therapeutic target in breast cancer

    TYRO3 as a potential therapeutic target in breast cancer by Ekyalongo, Roudy Chiminch, Mukohara, Toru, Funakoshi, Yohei, Tomioka, Hideo, Kataoka, Yu, Shimono, Yohei, Chayahara, Naoko, Toyoda, Masanori, Kiyota, Naomi, Minami, Hironobu

    Published in Anticancer research
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Ptdglc-Enriched Lipid Rafts Are a Novel Platform for Apoptosis Signaling in Human Neutrophilic Lineage Cells

    Ptdglc-Enriched Lipid Rafts Are a Novel Platform for Apoptosis Signaling in Human Neutrophilic Lineage Cells by Ekyalongo, Roudy Chiminch, Yokoyama, Noriko, Nakayama, Hitoshi, Ogawa, Hideoki, Tabe, Yoko, Takamori, Kenji, Hirabayashi, Yoshio, Iwabuchi, Kazuhisa

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line

    Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line by Funakoshi, Yohei, Mukohara, Toru, Tomioka, Hideo, Ekyalongo, Roudy Chiminch, Kataoka, Yu, Inui, Yumiko, Kawamori, Yuriko, Toyoda, Masanori, Kiyota, Naomi, Fujiwara, Yutaka, Minami, Hironobu

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line

    Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line by Ekyalongo, Roudy Chiminch, Mukohara, Toru, Kataoka, Yu, Funakoshi, Yohei, Tomioka, Hideo, Kiyota, Naomi, Fujiwara, Yutaka, Minami, Hironobu

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Abstract C95: Reversibility of acquired resistance and “addiction” to MET inhibitors

    Abstract C95: Reversibility of acquired resistance and “addiction” to MET inhibitors by Funakoshi, Yohei, Mukohara, Toru, Tomioka, Hideo, Ekyalongo, Roudy Chiminch, Kataoka, Yu, Shimono, Yohei, Chayahara, Naoko, Toyoda, Masanori, Kiyota, Naomi, Fujiwara, Yutaka, Minami, Hironobu

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract C186: Tyro3 is a potential target for the treatment of breast cancer

    Abstract C186: Tyro3 is a potential target for the treatment of breast cancer by Ekyalongo, Roudy Chiminch, Mukohara, Toru, Funakoshi, Yohei, Tomioka, Hideo, Kataoka, Yu, Shimono, Yohei, Toyoda, Masanori, Kiyota, Naomi, Fujiwara, Yutaka, Minami, Hironobu

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: